Epidemiology - The REACT Programme

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-273

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Pending
  • Research Location

    United Kingdom
  • Lead Research Institution

    UK Dementia Research Institute
  • Research Priority Alignment

    N/A
  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease transmission dynamics

  • Special Interest Tags

    N/A

  • Study Subject

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The REACT programme, the largest of its kind, is a series of studies that are monitoring how the COVID-19 virus is spreading across England. Commissioned by the Department of Health and Social Care, the REACT series of studies are being carried out in partnership with Imperial College Healthcare NHS Trust and Ipsos MORI. The research is offering insight into infection rates broken down by geography, age, sex, ethnicity, key worker status and symptoms. REACT is the largest study of its kind and offers a comprehensive approach to antigen and antibody testing including a large sample (5000+) of keyworkers. REACT 1 and REACT 2 participants are to be followed up via NHS records. Patients who tested positive for COVID-19 (either antigen or antibody) will be followed up for neurological diseases via NHS records.